219 related articles for article (PubMed ID: 32562682)
1. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial.
Mohr JP; Overbey JR; Hartmann A; Kummer RV; Al-Shahi Salman R; Kim H; van der Worp HB; Parides MK; Stefani MA; Houdart E; Libman R; Pile-Spellman J; Harkness K; Cordonnier C; Moquete E; Biondi A; Klijn CJM; Stapf C; Moskowitz AJ;
Lancet Neurol; 2020 Jul; 19(7):573-581. PubMed ID: 32562682
[TBL] [Abstract][Full Text] [Related]
2. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.
Mohr JP; Parides MK; Stapf C; Moquete E; Moy CS; Overbey JR; Al-Shahi Salman R; Vicaut E; Young WL; Houdart E; Cordonnier C; Stefani MA; Hartmann A; von Kummer R; Biondi A; Berkefeld J; Klijn CJ; Harkness K; Libman R; Barreau X; Moskowitz AJ;
Lancet; 2014 Feb; 383(9917):614-21. PubMed ID: 24268105
[TBL] [Abstract][Full Text] [Related]
3. Impact of tailored multimodal treatment for unruptured brain arteriovenous malformation: comparison with a randomized trial of unruptured brain arteriovenous malformations.
Ikedo T; Yamamoto EH; Mori H; Niwa A; Ozaki S; Kushi Y; Shimonaga K; Hamano E; Yamada K; Imamura H; Iihara K; Kataoka H
Acta Neurochir (Wien); 2023 Dec; 165(12):3779-3785. PubMed ID: 37779178
[TBL] [Abstract][Full Text] [Related]
4. Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial.
CARE pilot trial collaboration
Lancet Neurol; 2024 Jun; 23(6):565-576. PubMed ID: 38643777
[TBL] [Abstract][Full Text] [Related]
5. The NASSAU (New ASSessment of cerebral Arteriovenous Malformations yet Unruptured) Analysis: Are the Results From The ARUBA Trial Also Applicable to Unruptured Arteriovenous Malformations Deemed Suitable for Gamma Knife Surgery?
Karlsson B; Jokura H; Yang HC; Yamamoto M; Martinez R; Kawagishi J; Guo WY; Beute G; Pan DHC; Aiyama H; Chung WY; Söderman M; Yeo TT
Neurosurgery; 2019 Jul; 85(1):E118-E124. PubMed ID: 30295870
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Unruptured Brain Arteriovenous Malformations: A Single-Center Experience of 86 Patients and a Critique of the A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) Trial.
Link TW; Winston G; Schwarz JT; Lin N; Patsalides A; Gobin P; Pannullo S; Stieg PE; Knopman J
World Neurosurg; 2018 Dec; 120():e1156-e1162. PubMed ID: 30218805
[TBL] [Abstract][Full Text] [Related]
7. Radiosurgery for Cerebral Arteriovenous Malformations in A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA)-Eligible Patients: A Multicenter Study.
Ding D; Starke RM; Kano H; Mathieu D; Huang P; Kondziolka D; Feliciano C; Rodriguez-Mercado R; Almodovar L; Grills IS; Silva D; Abbassy M; Missios S; Barnett GH; Lunsford LD; Sheehan JP
Stroke; 2016 Feb; 47(2):342-9. PubMed ID: 26658441
[TBL] [Abstract][Full Text] [Related]
8. Unruptured Brain Arteriovenous Malformations: Primary ONYX Embolization in ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients.
Singfer U; Hemelsoet D; Vanlangenhove P; Martens F; Verbeke L; Van Roost D; Defreyne L
Stroke; 2017 Dec; 48(12):3393-3396. PubMed ID: 29114088
[TBL] [Abstract][Full Text] [Related]
9. Microsurgery for Unruptured Cerebral Arteriovenous Malformations in the National Inpatient Sample is More Common Post-ARUBA.
Birnbaum LA; Straight M; Hegde S; Lacci JV; de Leonni Stanonik M; Mascitelli JR; McDougall CM; Caron JR
World Neurosurg; 2020 May; 137():e343-e346. PubMed ID: 32032786
[TBL] [Abstract][Full Text] [Related]
10. The benefit of radiosurgery for ARUBA-eligible arteriovenous malformations: a practical analysis over an appropriate follow-up period.
Tonetti DA; Gross BA; Atcheson KM; Jankowitz BT; Kano H; Monaco EA; Niranjan A; Flickinger JC; Lunsford LD
J Neurosurg; 2018 Jun; 128(6):1850-1854. PubMed ID: 28665253
[TBL] [Abstract][Full Text] [Related]
11. Treatment Outcomes of A Randomized Trial of Unruptured Brain Arteriovenous Malformation-Eligible Unruptured Brain Arteriovenous Malformation Patients.
Lang M; Moore NZ; Rasmussen PA; Bain MD
Neurosurgery; 2018 Sep; 83(3):548-555. PubMed ID: 29040773
[TBL] [Abstract][Full Text] [Related]
12. Gamma Knife Radiosurgery for ARUBA-Eligible Patients with Unruptured Brain Arteriovenous Malformations.
Kim BS; Yeon JY; Kim JS; Hong SC; Shin HJ; Lee JI
J Korean Med Sci; 2019 Sep; 34(36):e232. PubMed ID: 31538418
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes of unruptured arteriovenous malformations with a subgroup analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-eligible patients.
Nerva JD; Mantovani A; Barber J; Kim LJ; Rockhill JK; Hallam DK; Ghodke BV; Sekhar LN
Neurosurgery; 2015 May; 76(5):563-70; discussion570; quiz 570. PubMed ID: 25635891
[TBL] [Abstract][Full Text] [Related]
14. Outcome of microsurgical excision of unruptured brain arteriovenous malformations in ARUBA-eligible patients.
Javadpour M; Al-Mahfoudh R; Mitchell PS; Kirollos R
Br J Neurosurg; 2016 Dec; 30(6):619-622. PubMed ID: 27172987
[TBL] [Abstract][Full Text] [Related]
15. Interventions for treating brain arteriovenous malformations in adults.
Zuurbier SM; Al-Shahi Salman R
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD003436. PubMed ID: 31503327
[TBL] [Abstract][Full Text] [Related]
16. Functional impairments for outcomes in a randomized trial of unruptured brain AVMs.
Mohr JP; Overbey JR; von Kummer R; Stefani MA; Libman R; Stapf C; Parides MK; Pile-Spellman J; Moquete E; Moy CS; Vicaut E; Moskowitz AJ; Harkness K; Cordonnier C; Biondi A; Houdart E; Berkefeld J; Klijn CJM; Barreau X; Kim H; Hartmann A;
Neurology; 2017 Oct; 89(14):1499-1506. PubMed ID: 28878048
[TBL] [Abstract][Full Text] [Related]
17. Intervention for A randomized trial of unruptured brain arteriovenous malformations (ARUBA) - Eligible patients: An evidence-based review.
Hong CS; Peterson EC; Ding D; Sur S; Hasan D; Dumont AS; Chalouhi N; Jabbour P; Starke RM
Clin Neurol Neurosurg; 2016 Nov; 150():133-138. PubMed ID: 27656780
[TBL] [Abstract][Full Text] [Related]
18. Microsurgery for cerebral arteriovenous malformations: subgroup outcomes in a consecutive series of 288 cases.
Schramm J; Schaller K; Esche J; Boström A
J Neurosurg; 2017 Apr; 126(4):1056-1063. PubMed ID: 27285541
[TBL] [Abstract][Full Text] [Related]
19. Microsurgery for ARUBA Trial (A Randomized Trial of Unruptured Brain Arteriovenous Malformation)-Eligible Unruptured Brain Arteriovenous Malformations.
Wong J; Slomovic A; Ibrahim G; Radovanovic I; Tymianski M
Stroke; 2017 Jan; 48(1):136-144. PubMed ID: 27856955
[TBL] [Abstract][Full Text] [Related]
20. Updates in arteriovenous malformation management: the post-ARUBA era.
Feghali J; Huang J
Stroke Vasc Neurol; 2020; 5(1):34-39. PubMed ID: 32411406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
